Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester...

23
Hypertension Therapeutics Lecture Semester 6

Transcript of Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester...

Page 1: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Hypertension

Therapeutics Lecture

Semester 6

Page 2: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Lesson Outcomes:Therapeutics of HypertensionSemester 6

Contents IMU DomainReview of the cardiovascular risk factors 1,4

Non-pharmacological measures to reduce blood pressure1,2

The common classes of anti-hypertensive drugs 1

Adverse effects of anti-hypertensive drugs 1

Selecting an anti-hypertensive drug 1,2,7

Influence of co-morbid factors in drug selection 2,7

Monitoring drug therapy 2,7

Resistant hypertension 1,2

Hypertensive urgencies/emergencies 1,2

Hypertension and pregnancy 1,2

(Not covered: Detection and evaluation of hypertension)

Page 3: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Case Study 1Mr. C, a 64-year-old ex-banker, is found on routine medical check up to have a BP of 170/100.

He is asymptomatic and is usually in good health. He does not smoke and stoppeddrinking alcohol 4 years ago. There is no known family history of hypertension but hisfather died in his 50’s possibly from acute MI.

On examination: BMI 27. BP 170/90. Otherwise physical examination is unremarkable.

Investigation:Total cholesterol: 6.5 mmol/L, LDL 4.8 mmol/L, HDL 1.3mmol/L. ECG: sinus rhythm with no signs of LVH.

How would you advice him?

Page 4: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Non-Pharmacological measures to reduce BP

Weight Reduction: BMI < 23Sodium Intake (< 100 mEq/L of Na or 6g NaCl a day)

Diet Plan Physical Exercise (aerobic exercise ≥ 30 minutes ≥ 3 times/wk)

Avoid/Reduce Alcohol (<21 units/wk ♂ ; < 14 units/wk ♀: 1 unit = 9 g of alcohol)

Stop Smoking

Page 5: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Case Study 1

Mr. C’s BP is found on follow-up to be persistently in the range of 160-170/90-100.

He is diagnosed to have hypertension.

Before commencing drug treatment what else would you discuss with the patient?

• Explain the diagnosis• Explain risk of not treating • Explain need for long-term treatment• Discuss medication to be used and possible side-effects• Inform need for regular follow-up • Ensure continuation of non-pharmacological measures

Page 6: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Case Study 1

Mr. C was started on a thiazide diuretic (other drug choices also possible)

Thiazide Diuretics (eg. hydrochlorothiazide, chlorothiazide)

What are the possible side-effects of thiazide diuretics?

Hypokalaemia

Hyperuricaemia ( can precipitate gout)

Hyperglycaemia (can worsen diabetes in high doses)

Hyponatremia

Alkalosis

Monitor renal profile

Monitor diabetes

Page 7: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Case study 1

After one month Mr. C is reviewed in the clinic. His BP is 160/90.

Renal profile and serum uric acid are normal.

It is decided to add a second drug to his treatment regimen.

An angiotensin-converting enzyme inhibitor (ACEI) is added

What are the possible side-effects of ACEIs?

Dry cough

Hyperkalaemia (care with K supplements, spironolactone)

Worsen/precipitate renal failure (contraindicated in bilateral renal artery stenosis)

First dose hypotension (care in dehydrated patients)

Allergic rashes

Angioedema

Contraindicated in pregnancy

Monitor renal function

Page 8: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Case Study 1

Mr. C develops cough with the ACE Inhibitor and is changed to an angiotensin-receptor

blocker (ARB)

What are the possible side-effects of ARBs?

Hyperkalaemia

Renal impairment

Hyponatremia

Hypotension

Contraindicated in pregnancy

Monitor renal function

Avoid in bilateral renal artery stenosis

Page 9: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Case Study 1

If Mr. C’s blood pressure is still not controlled what would you do?

1. Check adherence to medication

2. Check if carrying out non-pharmacological measures

3. Check if there are any drug interactions: alcohol, NSAIDS

4. Recheck for causes of secondary hypertension

If Mr. C requires a third drug to achieve target BP what would you add?

A calcium channel blocker (CCB) is used.

Possible side-effects:

Headaches, dizziness, flushing

Oedema

Constipation

(Short-acting CCBs should be avoided because of the higher risk of adverse cardiac

events; long-acting or sustained release preparations preferred)

Page 10: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Case Study 2

A 43-year-old woman with diabetes for 10 years and hypertension for 5 years is seen in

the MOPD for follow-up.

Her current medication is metformin 500 mg tds, gliclazide 80 mg od, simvastatin 40 mg

on, hydrochlorothiazide 12.5 mg od, telmisartan 80 mg od and amlodipine 5 mg od.

Her BP is 150/90 and the medical officer decides to add metoprolol 50 mg bd.

Questions for discussion:

Can thiazide diuretics be used in diabetic patients?

Can beta-blockers be used in diabetics?

Page 11: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Case Study 2

Thiazide diuretics may worsen diabetes by causing hyperglycaemia. However in clinical trials, there is no difference in cardiovascular outcomes between

different anti-hypertensive drugs as long as BP control is achieved. Many guidelines recommend that in diabetics, diuretics may be added to the anti-

hypertensive regime to achieve target BP1,2.

Low doses recommended.

RAS blockers is the first-line treatment unless contraindicated.

1. ASH Position Paper: Treatment of Hypertension in Patients with Diabetes.

The Journal of Clinical Hypertension 2008; 10: (issue 9) 707-713

2.The JNC 7 Report. JAMA. 2003; 289: 2560-2571

Page 12: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Case Study 2

Beta-blockers in uncomplicated hypertension: In hypertensive patients without diabetes, starting β-blockers (especially if combined

with diuretics) results in a higher incidence of new-onset diabetes1. β-blockers are not recommended as first-line treatment of hypertension unless there

is a compelling indication2.

In diabetes with hypertension: Cardiovascular outcomes are improved by achieving target BP. β-blockers can be added on to the treatment regime to achieve target BP3,4. Newer generation β-blockers (those with ‘vasodilating’ effects: carvedilol) preferred

over older β-blockers (atenolol, metoprolol)

1. Diabetes Care. 2006; 29(5);1167-1169.2. NICE clinical guideline 34. Hypertension: management of hypertension in adults in primary care. June 2006.3. The JNC 7 Report. JAMA. 2003; 289: 2560-2571.4. The Journal of Clinical Hypertension. 2008; 10: (issue 9) 707-713.

Page 13: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Case Study 2

Possible side-effects if a β-blocker is used:

Fatigue

Bradycardia, heart block

Bronchospasm (avoid in asthma)

Impotence in males

Metabolic:

Hyperglycaemia

Adverse lipid profile changes (↑TG ↓HDL-C)

May mask symptoms of hypoglycaemia/hyperthyroidism

β-blockers should not be stopped suddenly; tail off over 1-2 weeks

Page 14: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Choice of drug treatment

There is no ‘fixed rule’ as to which drug to start a particular patient on

Choice is best ‘individualized’ based on:

Type and severity of hypertension

Age

Presence of co-morbid medical conditions

Cost/economics

Ethnicity (more research needed)

Page 15: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Initial Treatment of Hypertension(without other co-morbid risk factors)

A = ACE Inhibitor (or ARB)

C = Calcium-Channel Blocker

D = Thiazide-Type DiureticBritish Hypertension Society / NICE clinical guideline 34 (2006)

Younger than 55 55 Years Or Older

A C or D

A + C or A + D

A + C + D

Page 16: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Co-morbid Conditions and Choice of Drugs in Hypertension

Diabetes/Chronic Renal Disease

ACEIs or ARBs

Stroke ACEIs ± Diuretics

IHD/Angina β-blockers

CCBs (long-acting)

Post-AMI/Heart Failure β-blockers and ACEIs

Elderly/Isolated Systolic Hypertension

Diuretics or CCBs

The JNC 7 Report. JAMA. 2003; 289: 2560-2571

Page 17: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Starting hypertension treatment

• Drug therapy is often initiated with a single drug at a low dose.• Monitor for response and side-effects.• Monotherapy lowers BP to target levels in only about half of patients with mild to

moderate hypertension.• If target BP is not achieved it may be preferable to add a second drug from another

class rather than to keep increasing the dose of the first.• For those with moderate/severe hypertension (BP > 160/100) consider starting with a

2 drug combination.• Diabetics often require more than one drug and often up to 3 or 4 to achieve target

BP levels.

Clinical Practice Guidelines: Management of Hypertension (3 rd Edition) 2008Academy of Medicine Malaysia

Page 18: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Targets

Patient Group Target BP

Most Patients BP < 140/85

Diabetics BP <130/80

(Proteinuria >1g/day BP <125/75)

Clinical Practice Guidelines: Management of Hypertension (3rd Edition) 2008Academy of Medicine Malaysia

Page 19: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Resistant Hypertension

Consider :• Compliance • Drug Interactions/Excessive Sodium Intake/Alcohol• Renovascular Disease• Secondary Hypertension

Page 20: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Hypertensive Urgencies and Emergencies

Usually BP > 220/120

Urgencies• Asymptomatic or symptomatic • Usually admit: oral treatment

Emergencies:(acute LVF, dissecting aortic aneurysm, hypertensive encephalopathy, acute renal failure)

• Admit• IV treatment: labetalol, nitrates, hydrallazine, sodium nitroprusside

Page 21: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

Hypertension and Pregnancy

Differentiate between:1. Pregnancy-induced hypertension / pre-eclampsia.2. Pre-existing / chronic hypertension (hypertension that is present before pregnancy or

diagnosed before 20th week of gestation or first diagnosed in pregnancy and persists beyond D42 post-partum).

Suitable drugs:• α-Methyldopa• Labetalol• Nifedipine(ACEIs are contraindicated because of foetal abnormalities and death)

• For pregnancy-induced hypertension, long term follow up is advised because of the higher likelihood of developing hypertension.

• For pre-existing hypertension, pregnancy is best planned and BP well controlled before conceiving.

Page 22: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

“The most effective treatment prescribed by the most careful clinician will

control hypertension only if the patients are motivated. Motivation improves

when patients have positive experiences with, and trust in, the clinician. “

JNC VII 2003

Page 23: Hypertension Therapeutics Lecture Semester 6. Lesson Outcomes: Therapeutics of Hypertension Semester 6 ContentsIMU Domain Review of the cardiovascular.

End of lecture

Thank you